QuickView for T-lymphoma invasion and metastasis-inducing protein 1 (biogroup)

1. Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
2. Gene expression profiles of multiple myeloma before treatment
3. OMIM - Neurodevelopmental and Related Disorders
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens

There were no matches for T-lymphoma invasion and metastasis-inducing protein 1

1. Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Ce…
2. Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Lo…
3. PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibit…
4. An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell …
5. Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, …